colitis and glp-1 Engineered probiotic restores signaling to ameliorate fiber-deficiency exacerbated GLP-1 Receptor Agonists in Obese

Annie Moore is an internal medicine doctor who is board certified in obesity medicine and has extensive experience prescribing the newest weight loss medications to her patients

Limitations of Use: The use of VYVANSE is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions (5.5), Use in Specific Populations (8.4)]

individuals could not have evidence of prior direct-acting antiviral (DAA) treatment, HIV, or Hepatitis B infection

It is currently being tested in early clinical trials for obesity and NASH

Extensive Personal Human Gut Microbiota Culture Collections Characterized and Manipulated in Gnotobiotic Mice